| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
245,006 |
214,876 |
$10.12M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
64,520 |
57,658 |
$4.51M |
| 87428 |
|
57,666 |
50,867 |
$3.05M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
53,797 |
47,350 |
$1.36M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
116,451 |
54,477 |
$1.25M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17,395 |
15,035 |
$800K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
75,103 |
66,988 |
$752K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30,043 |
26,954 |
$534K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37,645 |
32,403 |
$471K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,008 |
2,537 |
$92K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,372 |
3,842 |
$81K |
| 99215 |
Prolong outpt/office vis |
1,058 |
1,019 |
$71K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
8,305 |
7,173 |
$36K |
| 99205 |
Prolong outpt/office vis |
222 |
208 |
$20K |
| 87807 |
|
1,990 |
1,776 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,161 |
13,363 |
$15K |
| 96127 |
|
3,450 |
3,083 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
546 |
517 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
664 |
508 |
$11K |
| S9083 |
Global fee urgent care centers |
568 |
525 |
$11K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
632 |
572 |
$8K |
| 81003 |
|
15,597 |
13,985 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
404 |
360 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,475 |
2,142 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,080 |
980 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
106 |
87 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
463 |
413 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
246 |
229 |
$2K |
| 90688 |
|
143 |
137 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
195 |
156 |
$1K |
| 99051 |
|
8,103 |
7,693 |
$1K |
| 74018 |
|
71 |
68 |
$1K |
| 90461 |
|
77 |
67 |
$1K |
| 86308 |
|
279 |
236 |
$883.97 |
| 99401 |
|
47 |
39 |
$788.92 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
53 |
44 |
$731.38 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
64 |
58 |
$691.08 |
| 90633 |
|
253 |
242 |
$413.67 |
| 81025 |
|
88 |
80 |
$377.91 |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$244.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
26 |
20 |
$242.84 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
19 |
12 |
$94.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
42 |
38 |
$2.63 |
| 99499 |
|
1,147 |
1,026 |
$0.00 |
| 3725F |
|
959 |
834 |
$0.00 |
| 90734 |
|
35 |
31 |
$0.00 |
| 3008F |
|
8,047 |
7,269 |
$0.00 |
| 3351F |
|
794 |
701 |
$0.00 |
| 99000 |
|
291 |
279 |
$0.00 |